Phase I clinical trial of the chimeric monoclonal antibody (c30.6) in patients with metastatic colorectal cancer. [electronic resource]
Producer: 20010419Description: 4674-83 p. digitalISSN:- 1078-0432
- Adult
- Aged
- Animals
- Antibodies, Monoclonal -- adverse effects
- CHO Cells
- Chromatography
- Chromatography, Gel
- Colorectal Neoplasms -- immunology
- Cricetinae
- Dose-Response Relationship, Drug
- Enzyme-Linked Immunosorbent Assay
- Female
- Humans
- Iodine Radioisotopes -- metabolism
- Liver -- drug effects
- Male
- Mice
- Middle Aged
- Neoplasm Metastasis
- Time Factors
- Tomography, Emission-Computed
- Tomography, Emission-Computed, Single-Photon
- Tomography, X-Ray Computed
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.